Coronavirus Russia: Putin says world’s first vaccine has been approved for use

President says one of his daughters has already been inoculated with the experimental shot

Oliver Carroll
Tuesday 11 August 2020 10:38 BST
Coronavirus in numbers

Russia has announced the world’s first vaccine for Covid-19 amid concerns it may not have fully tested its product.

Announcing regulatory approval for a test vaccine produced by Moscow’s Gamaleya Institute after shortened trials, Vladimir Putin claimed testing had demonstrated the product was safe, worked effectively and formed long-term immunity.

“One of my daughters did the inoculation herself,” he said before a cabinet meeting on Tuesday morning. “After the first injection, her temperature went up to 38, but by the next day it was just a little over 37.”

According to deputy prime minister Tatyana Golikova, Russia plans to begin inoculating medical staff in August, with mass vaccination starting early next year. Health minister Mikhail Murashko said a course of two shots would provide immunity for up to two years.

Russia has embraced the race to approve the world’s first vaccine, with Kirill Dmitriev, head of the country’s sovereign wealth fund, likening the search to the Soviet launch of the world’s first satellite in 1957.

Moscow announced the new coronavirus vaccine would be codenamed Sputnik V, in reference to that success.

Russia is one of two dozen countries involved in vaccine trials. In July, the UK accused Russia of hacking data from advanced trials at the University of Oxford – to the consternation of Moscow.

The Russian vaccine uses adapted strains of the adenovirus, a virus that usually causes the common cold, but researchers have failed to produce evidence of its safety or efficacy. Testing was carried out on soldiers and medical students, with regulatory approval arriving several months ahead of the scheduled completion of clinical trials.

That speed and lack of transparency has fuelled concerns that geopolitics may have been prioritised at the expense of science.

On Monday, an association representing Russian pharmaceutical companies wrote to the health ministry to warn against the lack of testing, noting that so far the vaccine had only been tested on “less than a hundred people” when final, phase-3 trials usually require thousands of volunteers.

Francois Balloux, director of the UCL Genetics Institute, described the decision to approve the "untested" vaccine as "reckless," "foolish" and "unethical." Any problem with the Russian vaccine would have "disastrous" consequences, he added — "both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.”

Mikhail Favorov, an epidemiologist at the US Centre for Disease Control and Prevention who sat on the board of the Gamaleya Institute between 1989-90, has suggested his former colleagues knowingly cut corners in order to please political masters.

Writing in a social media post, he revealed he asked them for data about the adenovirus vaccine — but was left without a response.

“I hope with my whole heart that the vaccine will be protective and safe,” he said. “We’ll know soon enough if the vaccinated don’t get ill with Covid-19, which will be great. If they do get ill, we’ll know it doesn’t work, which is bad. But if people start dying at a proportion of one in a hundred or a thousand, then it will be especially bad, and for [the developers] who will face prison.”

At a congressional hearing last month, Anthony Fauci, the man leading the US coronavirus response effort, also warned about the dangers of an under-tested vaccine.

“I do hope that the Chinese and the Russians are actually testing the vaccine before they are administering the vaccine to anyone,” he said. “Claims of having a vaccine ready to distribute before you do testing is problematic in the very least.”

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies


Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in